0001721811-17-000003.txt : 20171213 0001721811-17-000003.hdr.sgml : 20171213 20171213144850 ACCESSION NUMBER: 0001721811-17-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171213 DATE AS OF CHANGE: 20171213 EFFECTIVENESS DATE: 20171213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neon Therapeutics, Inc. CENTRAL INDEX KEY: 0001694187 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-278190 FILM NUMBER: 171253639 BUSINESS ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 110 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-337-4701 MAIL ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 110 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D/A 1 primary_doc.xml X0708 D/A LIVE 0001694187 Neon Therapeutics, Inc. 40 ERIE STREET SUITE 110 CAMBRIDGE MA MASSACHUSETTS 02139 617-337-4701 DELAWARE None None Corporation true 2013 Hugh Dowd 40 Erie Street Suite 110 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Richard Gaynor, M.D. 40 Erie Street Suite 110 Cambridge MA MASSACHUSETTS 02139 Executive Officer Robert Ang, M.D. 40 Erie Street Suite 110 Cambridge MA MASSACHUSETTS 02139 Executive Officer Yasir Al-Wakeel 40 Erie Street Suite 110 Cambridge MA MASSACHUSETTS 02139 Executive Officer Robert Tepper 40 Erie Street Suite 110 Cambridge MA MASSACHUSETTS 02139 Director Eric Lander 40 Erie Street Suite 110 Cambridge MA MASSACHUSETTS 02139 Director Robert Kamen 40 Erie Street Suite 110 Cambridge MA MASSACHUSETTS 02139 Director Stephen Sherwin 40 Erie Street Suite 110 Cambridge MA MASSACHUSETTS 02139 Director Cary Pfeffer, M.D. 40 Erie Street Suite 110 Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b true 0001694187-17-000001 2016-12-28 false true false 0 106000001 105999996 5 false 25 0 0 0 false Neon Therapeutics, Inc. /s/Yasir Al-Wakeel Yasir Al-Wakeel Chief Financial Officer 2017-12-13